Do Anti-CD25 Monoclonal Antibodies Potentiate Posttransplant Diabetes Mellitus?

Transplantation Proceedings

Volumn 39, Issue 7, 2007, Pages 2248-2250

  Bayes B ^a   Pastor, M C ^a   Lauzurica, R ^a   Granada, M L ^a   Salinas, I ^a   Romero, R ^a  

^a HOSPITAL UNIVERSITARI GERMANS TRIAS I PUJOL   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

BASILIXIMAB; CALCINEURIN INHIBITOR; CYCLOSPORIN; INSULIN; METHYLPREDNISOLONE; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; ORAL ANTIDIABETIC AGENT; PREDNISONE; TACROLIMUS;

ACUTE GRAFT REJECTION; ADULT; ARTICLE; BODY MASS; BODY WEIGHT; CONTROLLED STUDY; DEMOGRAPHY; DIABETES MELLITUS; DRUG BLOOD LEVEL; FEMALE; GLUCOSE BLOOD LEVEL; HEPATITIS C; HUMAN; INCIDENCE; KIDNEY TRANSPLANTATION; LOGISTIC REGRESSION ANALYSIS; MAJOR CLINICAL STUDY; MALE; ORAL GLUCOSE TOLERANCE TEST; POSTOPERATIVE PERIOD; PRIORITY JOURNAL; RISK FACTOR; SEX RATIO;

ADULT; ANTIBODIES, MONOCLONAL; ANTIGENS, CD; BODY MASS INDEX; BODY WEIGHT; DIABETES MELLITUS; FEMALE; GRAFT REJECTION; HUMANS; IMMUNOSUPPRESSIVE AGENTS; INTERLEUKIN-2 RECEPTOR ALPHA SUBUNIT; KIDNEY TRANSPLANTATION; MALE; MIDDLE AGED; POSTOPERATIVE COMPLICATIONS; RECOMBINANT FUSION PROTEINS;

EID: 34548738237     PISSN: 00411345     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.transproceed.2007.06.021     Document Type: Article

References (10)

1. Gonzalez-Posada J.M., Hernandez D., Genis B.B., et al. Increased cardiovascular risk profile and mortality in kidney allograft recipients with posttransplant diabetes mellitus in Spain. Clin Transplant 20 (2006) 650
2. Gonzalez-Posada J.M., Hernandez D., Bayés Genis B., et al. Impact of diabetes mellitus on kidney transplant recipients in Spain. Nephrol Dial Transplant 19 suppl 3 (2004) iii57
3. Hjelmesaeth J., Hartmann A., Leivestad T., et al. The impact of early-diagnosed new-onset post-transplantation diabetes mellitus on survival and major cardiac events. Kidney Int 69 (2006) 588
4. Standards of Medical Care in Diabetes-2006. American Diabetes Association. Diabetes Care 29 (2006) S4
5. Armstrong K., Prins J., Beller E., et al. Should an oral glucose tolerance test be performed routinely in all renal transplant recipients?. Clin J Am Soc Nephrol 1 (2006) 100
6. Bayés B., Granada M.L., Pastor M.C., et al. Obesity, adiponectin and inflammation as predictors of new-onset diabetes mellitus after kidney transplantation. Am J Transplantation 7 (2007) 416
7. Midtvedt K., Hjelmesaeth J., Hartmann A., et al. Insulin resistance after renal transplantation: the effect of steroid dose reduction and withdrawal. J Am Soc Nephrol 15 (2004) 3233
8. Heisel O., Heisel R., Balshaw R., et al. New onset diabetes mellitus in patients receiving calcineurin inhibitors: a systematic review and meta-analysis. Am J Transplantation 4 (2004) 583
9. Baan C., van der Mast B., Klepper M., et al. Differential effect of calcineurin inhibitors, anti-CD25 antibodies and rapamycin on the induction of FOXP3 in human T cells. Transplantation 80 (2005) 110
10. Setoguchi R., Hori S., Takahashi T., et al. Homeostatic maintenance of natural Foxp3+CD25+CD4+ regulatory T cells by interleukin (IL)-2 and induction of autoimmune disease by IL-2 neutralization. J Exp Med 201 (2005) 723